What should procurement teams evaluate before selecting a supplier in the Gene Synthesis Market?

Prioritize documented screening compliance, guaranteed turnaround on your typical construct length, and published first-pass success rates for difficult sequences. Price per base matters least of the four [15]. Read More

How does enzymatic synthesis compare with phosphoramidite chemistry in practice?

Enzymatic routes handle repeat-rich and high-GC regions more reliably and generate less hazardous waste. Phosphoramidite still wins on cost and throughput for standard short constructs [6]. Read More

Who owns the intellectual property in a sequence ordered through the Gene Synthesis Market?

Standard contracts assign customer ownership of the submitted sequence, but design contributions made by the supplier can create ambiguity. Negotiate optimization-derived IP explicitly before the first order [16]. Read More

Is in-house benchtop synthesis worth the capital outlay?

It pays off only for laboratories running high volumes of short, non-complex constructs where same-day access changes experimental pace. Below roughly weekly ordering, outsourcing remains cheaper [24]. Read More

How long do biosecurity screening reviews typically delay an order?

Routine orders clear automatically. Flagged sequences trigger manual review that commonly adds several business days, occasionally longer for sequences with regulated-agent homology [20]. Read More

What integration challenges do buyers face when scaling orders in the Gene Synthesis Market?

API connectivity to laboratory information systems is inconsistent across suppliers, forcing manual order entry at volume. Verify programmatic ordering and structured result delivery before committing to a platform [25]. Read More

Which emerging use cases are underestimated by current buyers?

Biological data storage pilots and engineered microbial consortia for waste valorization are both moving from academic proof of concept toward funded programs. Neither is yet reflected in most demand forecasts [11]. Read More

Gene Synthesis Market (2026 - 2035)

ID: MRFR/HC/10104-HCR 128 Pages Rahul Gotadki Last Updated: September 15, 2026

Gene Synthesis Market Research Report: Size, Share, Trend Analysis By Applications (Synthetic Biology, Therapeutics, Vaccines, Genetic Engineering, Agricultural Biotechnology), By Product Type (Gene Libraries, Oligonucleotides, Plasmids, Gene Fragments), By Technology (Polymerase Chain Reaction, Microarray Technology, DNA Sequencing, Automated Synthesis), By End Use (Academic Research, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Gene Synthesis Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)15.2%

2025 Market SizeUSD 2.30 Billion

2035 Market SizeUSD 9.47 Billion

Key Players

GenScript Biotech

Twist Bioscience

Thermo Fisher Scientific

Integrated DNA Technologies

Azenta Life Sciences

Merck KGaA

Trends

Therapy Pipeline Depth Is the Structural Engine
Cost Curves Are Expanding the Addressable Base
Public Capital Is Underwriting Capacity

Opportunities

Enzymatic Writing for Difficult Sequences
Emerging-Market Localization
Subscription and Capacity-Reservation Models

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Summary |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Key Report Takeaways |
1. 2.1 By Synthesis Method |
2. 2.2 By Service Type and Application |
3. 2.3 By Geography
3 Market Size & Forecast (2021–2035) |
1. 3.1 Historical Market Size (2021–2025) |
2. 3.2 Current & Forecast Market Size (2026–2035) |
3. 3.3 Year-over-Year Growth Analysis
4 Driver Impact Analysis |
1. 4.1 Therapy Pipeline Depth |
2. 4.2 Cost Curve Compression |
3. 4.3 Public Biomanufacturing Capital |
4. 4.4 Computational Design Demand
5 Restraints Impact Analysis |
1. 5.1 Screening & Export-Control Compliance |
2. 5.2 Complex Construct Failure Rates |
3. 5.3 Price Commoditization
6 Opportunity Analysis |
1. 6.1 Enzymatic Writing for Difficult Sequences |
2. 6.2 Emerging-Market Localization |
3. 6.3 Subscription & Capacity-Reservation Models |
4. 6.4 Design-Data Monetization |
5. 6.5 Agricultural & Industrial Biology
7 Regional Analysis |
1. 7.1 North America | |
  1. 7.1.1 US | |
  2. 7.1.2 Canada | |
  3. 7.1.3 Mexico |
2. 7.2 Europe | |
  1. 7.2.1 Germany | |
  2. 7.2.2 UK | |
  3. 7.2.3 France | |
  4. 7.2.4 Italy | |
  5. 7.2.5 Spain | |
  6. 7.2.6 Nordic Countries | |
  7. 7.2.7 Russia | |
  8. 7.2.8 Rest of Europe |
3. 7.3 Asia-Pacific | |
  1. 7.3.1 China | |
  2. 7.3.2 India | |
  3. 7.3.3 Japan | |
  4. 7.3.4 South Korea | |
  5. 7.3.5 ASEAN | |
  6. 7.3.6 Rest of Asia-Pacific |
4. 7.4 South America | |
  1. 7.4.1 Brazil | |
  2. 7.4.2 Argentina | |
  3. 7.4.3 Rest of South America |
5. 7.5 Middle East & Africa | |
  1. 7.5.1 Saudi Arabia | |
  2. 7.5.2 UAE | |
  3. 7.5.3 South Africa | |
  4. 7.5.4 Egypt | |
  5. 7.5.5 Rest of Middle East & Africa
8 Future Outlook (2026–2035) |
1. 8.1 Computational Design as the Front Door |
2. 8.2 Platform Economics |
3. 8.3 Biosecurity Governance |
4. 8.4 Sustainability in Specification
9 Market Segmentation Analysis |
1. 9.1 By Synthesis Method | |
  1. 9.1.1 Chemical Oligonucleotide Synthesis | |
  2. 9.1.2 Gene Assembly – PCR-Mediated | |
  3. 9.1.3 Gene Assembly – Ligation-Mediated |
2. 9.2 By Service Type | |
  1. 9.2.1 Antibody DNA Synthesis | |
  2. 9.2.2 Custom Gene Synthesis (Long Constructs) | |
  3. 9.2.3 Viral DNA Synthesis | |
  4. 9.2.4 Sequence Design and Optimization Services | |
  5. 9.2.5 Cloning and Subcloning Services |
3. 9.3 By Application | |
  1. 9.3.1 Gene and Cell Therapy Developments | |
  2. 9.3.2 Vaccine Development | |
  3. 9.3.3 Diagnostics and Molecular Testing | |
  4. 9.3.4 Agricultural and Industrial Biotechnology | |
  5. 9.3.5 Academic and Basic Research |
4. 9.4 By End User | |
  1. 9.4.1 Biopharmaceutical Companies | |
  2. 9.4.2 Academic and Research Institutes | |
  3. 9.4.3 Contract Research and Manufacturing Organizations | |
  4. 9.4.4 Agricultural and Industrial Biotech Firms
10 Competitive Landscape |
1. 10.1 Market Share Analysis (2026) |
2. 10.2 Competitive Benchmarking Matrix |
3. 10.3 Company Profiles | |
  1. 10.3.1 GenScript Biotech | |
  2. 10.3.2 Twist Bioscience | |
  3. 10.3.3 Thermo Fisher Scientific | |
  4. 10.3.4 Integrated DNA Technologies | |
  5. 10.3.5 Azenta Life Sciences | |
  6. 10.3.6 Merck KGaA | |
  7. 10.3.7 Eurofins Genomics | |
  8. 10.3.8 Synbio Technologies | |
  9. 10.3.9 ATUM | |
  10. 10.3.10 Telesis Bio | |
  11. 10.3.11 Ansa Biotechnologies
11 Recent News & Developments
12 Report Scope & Methodology |
1. 12.1 Study Period & Base Year |
2. 12.2 Data Sources |
3. 12.3 Abbreviations
13 Detailed Sources & Citations
14 Frequently Asked Questions
15 LIST OF TABLES |
TABLE 1 Global Gene Synthesis Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Gene Synthesis Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis Matrix, 2026–2035 |
TABLE 4 Restraint Impact Analysis Matrix, 2026–2035 |
TABLE 5 Global Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 6 North America Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 7 Europe Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Asia-Pacific Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 South America Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Middle East & Africa Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Global Market Size, by Synthesis Method, 2021–2035 (USD Billion) |
TABLE 12 Global Market Size, by Service Type, 2021–2035 (USD Billion) |
TABLE 13 Global Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 14 Global Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 15 North America Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 16 Europe Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 17 Asia-Pacific Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 18 Competitive Benchmarking Matrix, 2026 |
TABLE 19 Company Profiles – Key Players |
TABLE 20 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 21 Report Scope & Methodology Summary |
TABLE 22 Detailed Sources & Citations Index
16 LIST OF FIGURES |
FIGURE 1 Market Dynamics – Drivers, Restraints, Opportunities |
FIGURE 2 Industry Value Chain Analysis |
FIGURE 3 Porter's Five Forces Analysis |
FIGURE 4 Global Market Size Trend, 2021–2035 (USD Billion) |
FIGURE 5 Year-over-Year Growth Curve, 2022–2035 |
FIGURE 6 Market Share by Synthesis Method, 2025 vs 2035 |
FIGURE 7 Market Share by Service Type, 2025 |
FIGURE 8 Market Share by Application, 2025 vs 2035 |
FIGURE 9 Market Share by End User, 2025 |
FIGURE 10 Regional Revenue Share, 2025 |
FIGURE 11 Regional CAGR Comparison, 2026–2035 |
FIGURE 12 Asia-Pacific Country Contribution, 2025 |
FIGURE 13 Competitive Landscape – Estimated Revenue Share Bands, 2026 |
FIGURE 14 Supplier Positioning Matrix – Capability vs Turnaround

Certified Researchers

Enquiry

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Synthesis Method	Chemical Oligonucleotide Synthesis; Gene Assembly – PCR-Mediated; Gene Assembly – Ligation-Mediated	Chemical Oligonucleotide Synthesis	Gene Assembly – Ligation-Mediated
By Service Type	Antibody DNA Synthesis; Custom Gene Synthesis (Long Constructs); Viral DNA Synthesis; Sequence Design and Optimization Services; Cloning and Subcloning Services	Antibody DNA Synthesis	Viral DNA Synthesis
By Application	Gene and Cell Therapy Developments; Vaccine Development; Diagnostics and Molecular Testing; Agricultural and Industrial Biotechnology; Academic and Basic Research	Gene and Cell Therapy Developments	Diagnostics and Molecular Testing
By End User	Biopharmaceutical Companies; Academic and Research Institutes; Contract Research and Manufacturing Organizations; Agricultural and Industrial Biotech Firms	Biopharmaceutical Companies	Contract Research and Manufacturing Organizations
By Geography	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Synthesis Method

Sub-Segment	Key Trend
Chemical Oligonucleotide Synthesis	Cycle-time optimization and reagent reduction extend incumbent economics
Gene Assembly – PCR-Mediated	Automation of assembly steps compresses standard turnaround
Gene Assembly – Ligation-Mediated	Preferred route for repeat-rich and structurally difficult constructs

Method choice increasingly follows sequence difficulty rather than supplier preference. Buyers now specify tolerance for error rate and length, and providers route the order internally to whichever chemistry clears the specification.

By Service Type

Sub-Segment	Key Trend
Antibody DNA Synthesis	Large variable-region panels ordered as single bundled projects
Custom Gene Synthesis (Long Constructs)	Growth in multi-kilobase vector and pathway orders
Viral DNA Synthesis	Vector engineering demand tied to therapy manufacturing
Sequence Design and Optimization Services	Expression-yield prediction bundled ahead of synthesis
Cloning and Subcloning Services	Attached to synthesis orders to shorten downstream workflows

Service bundling is the clearest commercial trend. Providers selling only sequence are losing ground to those delivering expression-ready material with validated downstream steps included.

By Application

Sub-Segment	Key Trend
Gene and Cell Therapy Developments	High iteration counts create recurring construct demand
Vaccine Development	Platform readiness sustains baseline ordering between outbreaks
Diagnostics and Molecular Testing	Decentralized assay design broadens the buyer base
Agricultural and Industrial Biotechnology	Trait and enzyme programs move from pilot to commercial scale
Academic and Basic Research	Grant cycles set predictable seasonal ordering rhythms

Application mix determines revenue quality. Therapy and diagnostics buyers reorder continuously, while vaccine demand remains episodic and sensitive to public health funding cycles.

By End User

Sub-Segment	Key Trend
Biopharmaceutical Companies	Shift from purchase orders to reserved-capacity agreements
Academic and Research Institutes	Procurement now conditioned on supplier screening compliance
Contract Research and Manufacturing Organizations	Fastest-growing buyer class as sponsors outsource more programs
Agricultural and Industrial Biotech Firms	Rising volumes tied to regulatory clarity on gene-edited products

Buyer sophistication is rising across all four groups. Contract organizations in particular are consolidating spend with fewer suppliers to negotiate throughput guarantees rather than unit discounts.

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”